Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Weikang Biological Technology is a Chinese biotechnology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and medical instruments. Based in Lianyungang, the company focuses on rapid diagnostic technologies, including colloidal gold chromatography, fluorescence immunochromatography, and enzyme-linked immunosorbent assays (ELISA). Their product portfolio covers a wide range of clinical needs, such as infectious disease screening, cardiac marker detection, and inflammation monitoring. Weikang Biological operates modern manufacturing facilities and serves both domestic and international healthcare markets with high-quality diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Weikang Biological Technology.